We’ve seen a rash of deals for all things spinal in recent weeks, from Stryker Corp.‘s (NYSE: SYK) $1.4 billion deal for K2M Group (NASDAQ: KTWO) to IZI Medical‘s acquisition of Benvenue Medical‘s vertebral augmentation systems.
What’s the occasion? Well, it’s that time of year when the big medical conferences loom. The Society for Minimally Invasive Spine Surgery (SMISS) took place in Las Vegas between September 6 and 8, and the North American Spine Society (NASS) do is about to get under way in Los Angeles from September 26 through the 29.
On the smaller scale of targets is Maxim Surgical, based in Richardson, Texas, which was acquired by Fuse Medical (OTC: FXMD), also in Richardson. Palm Springs Partners, LLC, dba Maxim Surgical, designs and manufactures spinal interbody spacers. Its X-Treme Fusion System has FDA 510(k) clearance. No price was disclosed.
Amedica (NASDAQ: AMDA) sold its spine portfolio to CTL Medical Corporation for up to $10 million on September 6. The portfolio includes metal and silicon nitride spine products, as well as access to future silicon nitride spine technologies sold under the brand names of Taurus, Preference and Valeo.
In Germany, Johnson & Johnson Medical GmbH (NYSE: JNJ) picked up Emerging Implant Technologies GmbH, a privately held manufacturer of 3D-printed titanium interbody implants for spinal fusion surgery.
